Aequus Pharmaceuticals Inc. filed its Annual on Jun 30, 2022 for the period ending Dec 31, 2021. In this report its auditor, Dale Matheson Carr-Hilton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 CAD | -16.67% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.89M | |
+47.36% | 765B | |
-6.16% | 354B | |
+20.37% | 331B | |
+9.51% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.08% | 164B | |
-2.22% | 162B |
- Stock Market
- Equities
- AQS Stock
- News Aequus Pharmaceuticals Inc.
- Aequus Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt